Evaluation of Ocular Irritation Sensitivity: Implications of Clinical Parameters, Pain Sensitivity, and Tear Neuromediator Profiles

<b>Background/Objectives:</b> Sensitivity to ocular irritation varies among individuals, being influenced by clinical, subjective, and biochemical factors. This study aimed to evaluate individual variability in ocular irritation sensitivity, focusing on clinical parameters, pain perception, and tear neuromediator profiles. <b>Methods:</b> Sixty female participants aged 20-40 were classified into high-sensitivity and low-sensitivity groups based on their response to an irritant (Tween20). Clinical assessments included the ocular surface disease index (OSDI), tear break-up time (TBUT), Schirmer test, and corneal touch threshold measured with the Cochet-Bonnet esthesiometer. Pain sensitivity was assessed using the pain sensitivity questionnaire (PSQ), and tear neuromediators were quantified in tear samples before and after stimulation. The concentrations of calcitonin gene-related peptide (CGRP), nerve growth factor, neuropeptide Y, vasoactive intestinal peptide (VIP), and substance P were measured using an enzyme-linked immune sorbent assay (ELISA). <b>Results:</b> The high-sensitivity group exhibited significantly higher OSDI scores (<i>p</i> = 0.038). No significant differences were observed in TBUT, corneal staining scores, or Schirmer's test results. The PSQ results revealed that the high-sensitivity group had lower total and moderate pain scores (<i>p</i> = 0.037 and <i>p</i> = 0.040, respectively). An analysis of the tear neuromediator showed elevated baseline CGRP levels (<i>p</i> = 0.017) and a significant post-stimulation increase in substance P (<i>p</i> = 0.021) in the high-sensitivity group. <b>Conclusions:</b> These findings emphasize the value of combining clinical, subjective, and biochemical measures to understand sensitivity to ocular irritation. This comprehensive approach may guide the development of safer cosmetic formulations and improve safety assessment protocols.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2024-12-29
DOI
https://doi.org/10.3390/jcm14010138
Citations
1
Primary Topic
Ocular Surface and Contact Lens
Type
article
Field-Weighted Citation Impact
0.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of Ocular Irritation Sensitivity: Implications of Clinical Parameters, Pain Sensitivity, and Tear Neuromediator Profiles

Kyung Chul Yoon, Hyun Jee Kim, Seoyoung Kim, Hoon‐In Choi et al.
1 citations
Journal of Clinical Medicine
Ocular Surface and Contact Lens
0.54
article

Evaluation of Ocular Irritation Sensitivity: Implications of Clinical Parameters, Pain Sensitivity, and Tear Neuromediator Profiles

Kyung Chul Yoon, Hyun Jee Kim, Seoyoung Kim, Hoon‐In Choi, Ji Suk Choi, Sodam Park, Ja Young Moon, Ho Sung Yoon
article en
1 citations

Abstract

<b>Background/Objectives:</b> Sensitivity to ocular irritation varies among individuals, being influenced by clinical, subjective, and biochemical factors. This study aimed to evaluate individual variability in ocular irritation sensitivity, focusing on clinical parameters, pain perception, and tear neuromediator profiles. <b>Methods:</b> Sixty female participants aged 20-40 were classified into high-sensitivity and low-sensitivity groups based on their response to an irritant (Tween20). Clinical assessments included the ocular surface disease index (OSDI), tear break-up time (TBUT), Schirmer test, and corneal touch threshold measured with the Cochet-Bonnet esthesiometer. Pain sensitivity was assessed using the pain sensitivity questionnaire (PSQ), and tear neuromediators were quantified in tear samples before and after stimulation. The concentrations of calcitonin gene-related peptide (CGRP), nerve growth factor, neuropeptide Y, vasoactive intestinal peptide (VIP), and substance P were measured using an enzyme-linked immune sorbent assay (ELISA). <b>Results:</b> The high-sensitivity group exhibited significantly higher OSDI scores (<i>p</i> = 0.038). No significant differences were observed in TBUT, corneal staining scores, or Schirmer's test results. The PSQ results revealed that the high-sensitivity group had lower total and moderate pain scores (<i>p</i> = 0.037 and <i>p</i> = 0.040, respectively). An analysis of the tear neuromediator showed elevated baseline CGRP levels (<i>p</i> = 0.017) and a significant post-stimulation increase in substance P (<i>p</i> = 0.021) in the high-sensitivity group. <b>Conclusions:</b> These findings emphasize the value of combining clinical, subjective, and biochemical measures to understand sensitivity to ocular irritation. This comprehensive approach may guide the development of safer cosmetic formulations and improve safety assessment protocols.

Journal of Clinical MedicineVol. 14(1)
Chonnam National University Hospital (KR), Amorepacific (South Korea) (KR)
Amorepacific Corporation, National Research Foundation, Chonnam National University, Korea Health Industry Development Institute, National Research Foundation of Korea, Ministry of Science and ICT, South Korea
Good health and well-being
Openalex Percentile: Top 25%
Ocular Surface and Contact Lens
0.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.